Abstract
A 67-year-old male was admitted due to lung cancer. He had received maintenance hemodialysis for diabetic nephropathy for 15 years. A chest roentgenogram showed a 2.8×2.2-cm coin lesion in the right upper lung field. CT-guided lung biopsy, chest CT-scanning, and PET led a diagnosis of primary lung cancer (cT1N2M0- IIIA, adenocarcinoma). An inferior vena cava filter was inserted for the prevention of recurring pulmonary thromboembolism, a pacemaker was established for complete AV block, and coronary angioplasty was performed due to angina pectoris prior to the detection of lung cancer. Under careful perioperative management, a right upper lobectomy with mediastinal lyphadenectomy was performed in November 2008, with no complications. The postoperative course was uneventful, and he was discharged 17 days after surgery. During the course of visiting an outpatient clinic, his tumor markers gradually increased again, and weekly paclitaxel therapy (60 mg/m2 Paclitaxel®) was administered for 4 courses with close observation on admission. Over the course of the chemotherapy, although hematological toxicities (grade 2 neutropenia) that required granulocyte colony-stimulating factor (G-CSF) developed, the serum CEA level was reduced to the normal range. There was no evidence of recurrence or metastasis of the lung cancer at 11 months postoperatively.
